According to MNTA and Sandoz, the generic-drugs division of Novartis, M-Enoxaparin is chemically indistinguishable from branded Lovenox, which is the legal requirement for FDA approval of an ANDA.
MNTA characterized all of the active elements in branded Lovenox and reverse-engineered the manufacturing process using chemical synthesis. Regards, Dew
Market Data 
Markets 
AI
